Home > Publications database > Erratum: Oral human papillomavirus (HPV) prevalence and genotyping among healthy adult populations in the United States and Europe: results from the PROGRESS (PRevalence of Oral hpv infection, a Global aSSessment) study. > print

001     303041
005     20250723114148.0
024 7 _ |a 10.1016/j.eclinm.2025.103335
|2 doi
024 7 _ |a pmid:40686674
|2 pmid
024 7 _ |a pmc:PMC12274941
|2 pmc
037 _ _ |a DKFZ-2025-01488
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Alemany, Laia
|b 0
245 _ _ |a Erratum: Oral human papillomavirus (HPV) prevalence and genotyping among healthy adult populations in the United States and Europe: results from the PROGRESS (PRevalence of Oral hpv infection, a Global aSSessment) study.
260 _ _ |a Amsterdam
|c 2025
|b Elsevier
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1753188984_32230
|2 PUB:(DE-HGF)
|x Erratum/Correction
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a [This corrects the article DOI: 10.1016/j.eclinm.2024.103018.].
536 _ _ |a 314 - Immunologie und Krebs (POF4-314)
|0 G:(DE-HGF)POF4-314
|c POF4-314
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Felsher, Marisa
|b 1
700 1 _ |a Giuliano, Anna R
|b 2
700 1 _ |a Waterboer, Tim
|0 P:(DE-He78)6b4ebb9791b983b5620c0caaf3468e30
|b 3
|u dkfz
700 1 _ |a Mirghani, Haitham
|b 4
700 1 _ |a Mehanna, Hisham
|b 5
700 1 _ |a Roberts, Craig
|b 6
700 1 _ |a Chen, Ya-Ting
|b 7
700 1 _ |a Lara, Núria
|b 8
700 1 _ |a Lynam, Mark
|b 9
700 1 _ |a Torres, Mayara
|b 10
700 1 _ |a Pedrós, Montse
|b 11
700 1 _ |a Sanchez, Emilio
|b 12
700 1 _ |a Spitzer, Jacque
|b 13
700 1 _ |a Sirak, Bradley
|b 14
700 1 _ |a Quirós, Beatriz
|b 15
700 1 _ |a Carretero, Gema
|b 16
700 1 _ |a Paytubi, Sonia
|b 17
700 1 _ |a Morais, Edith
|b 18
700 1 _ |a Pavón, Miquel Angel
|b 19
773 _ _ |a 10.1016/j.eclinm.2025.103335
|g Vol. 85, p. 103335 -
|0 PERI:(DE-600)2946413-4
|p 103335
|t EClinicalMedicine
|v 85
|y 2025
|x 2589-5370
909 C O |o oai:inrepo02.dkfz.de:303041
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)6b4ebb9791b983b5620c0caaf3468e30
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-314
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Immunologie und Krebs
|x 0
914 1 _ |y 2025
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b ECLINICALMEDICINE : 2022
|d 2024-12-31
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-31
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-31
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2023-05-02T08:53:12Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2023-05-02T08:53:12Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Anonymous peer review
|d 2023-05-02T08:53:12Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-31
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-31
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2024-12-31
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-31
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-31
915 _ _ |a IF >= 15
|0 StatID:(DE-HGF)9915
|2 StatID
|b ECLINICALMEDICINE : 2022
|d 2024-12-31
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2024-12-31
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2024-12-31
920 1 _ |0 I:(DE-He78)D320-20160331
|k D320
|l Infektionen und Krebs-Epidemiologie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)D320-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21